Continuous dosing versus interrupted therapy with ixekizumab: an integrated analysis of two phase 3 trials in psoriasis

A. Blauvelt, K. A. Papp, H. Sofen, M. Augustin, G. Yosipovitch, N. Katoh, U. Mrowietz, M. Ohtsuki, Y. Poulin, D. Shrom, R. Burge, K. See, L. Mallbris, K. B. Gordon

Research output: Contribution to journalArticlepeer-review

34 Scopus citations

Fingerprint

Dive into the research topics of 'Continuous dosing versus interrupted therapy with ixekizumab: an integrated analysis of two phase 3 trials in psoriasis'. Together they form a unique fingerprint.

Medicine & Life Sciences